Home »

Press releases

2010-08-11   Viropro reorganizes

---

2010-07-08   Viropro to seek supplemental listing

---

2010-06-01   Biologics to post record results

---

2010-04-28   Viropro initiates discussions with Intas Biopharmaceuticals Ltd

---

2010-04-14   Viropro, Inc. completes the acquisition of Biologics Process Development, Inc.

---

2010-01-07   Appointment of Dr Scott M. Brown as Chief Scientific Officer and Member of the Board

---

2009-12-16   Viropro to hold 100% of Biologics Process Development

---

2009-11-16   Neville G. Chamberlain Appointed Director

---

2009-09-22   Important Update to the Business Plan

---

2009-06-01   New Controlling Shareholder and appointment of Rajiv Datard

---

2009-05-28   Meeting of the shareholders approves change of control

---

2009-05-21   Biologics Process Development Inc. reiterates its interest in acquiring controlling stake

---

2009-02-06   Agreement is reached with Biologics Process Development

---

2008-10-05   Viropro Inc. Discussion on Partnerships

---

2008-05-26   Viropro Inc. Announces Settlement Agreement

---

2007-10-11   Viropro signs final contract with Intas Biopharmaceuticals and completes a US$ 1.5 million financing

---

2007-08-22   Intas Biopharmaceuticals to Finalize Agreement With Viropro

---

2007-05-10   Viropro Inc. and Intas Biopharmaceuticals Announce the Signature of a Binding MOU for the Development and Production of a Therapeutic Protein

---

2007-04-19   Viropro Issues Update Report On Development of a High Volume Sales Targeted Monoclonal Antibody

---

2007-04-12   VIROPRO AND INVITROGEN ENTERED INTO A COLLABORATION AGREEMENT

---

2007-03-19   SIGNATURE OF A CONTRACTUAL PARTNERSHIP FOR THE DEVELOPMENT OF A HIGH VOLUME SALES TARGETED MONOCLONAL ANTIBODY

---

2007-01-17   Appointment of Mr. Emilio S. Binavince to Viropro Board of Directors - A world renowned lawyer in international trade, business and tax planning, government litigation, and human rights

---

2006-11-07   Viropro signs a us$ 42 million collaborative agreement with biochallenge s.a. (Tunisia)

---

2006-11-02   Mr. Di Iorio appointed chief financial officer

---

2006-10-26   Viropro Inc. - New corporate presentation available on www.roadshows.tv

---

2006-10-26   Acquisition of a worldwide exclusive license- production of recombinant human interferon beta

---

2006-10-12   For immediate release / otc bb- nasdaq: vpro improvement of shareholder communications – agreement with echoes financial network

---

2006-09-28   Strategic partnership between viropro and University of Montreal synergy for the production of therapeutic proteins

---

2006-08-21   Update – mou with biochallenge

---

2006-07-15   viropro inc. Signs its first major agreement (mou) with potential revenues of u.s. $ 27 million agreement reached with biochallenge, a tunisia-based pharmaceutical company

---

2006-07-12   Le dr jean-marie dupuy en entrevue télévisée au canal argent de TVA

---

2006-07-12   Corporate and business update viropro committed to increase its visibility

---

2006-05-30   Viropro bolsters management team: two new appointments broaden financial scope of operations

---

2006-05-25   Professor Claude Griscelli appointed to viropro board of directors

---

2006-05-25   Creation of Theravax inc., to develop a hiv vaccine to be tested in canada a 100% owned subsidiary of viropro inc.

---

2006-05-09   Viropro inc.: an emerging player in the production and technology transfer of therapeutic proteins a world market worth 15 billion dollars u.s.

---

2006-04-20   Viropro teams up with Parteurop: a world renowned firm specializing in the bio-pharmaceutical domain

---

2006-04-11   Viropro inc. Acquires an exclusive licence for therapeutic proteins with Immuno Japan inc.

---

2006-04-10   Viropro inc. Files its annual financial statement with the SEC

---

2006-03-20   Viropro inc. Comments on ticker symbol change

---

2006-03-02   Viropro inc. Completes a $1,310, 000 u.s.debenture financing the company has the necessary financial resources to successfully pursue its development plan

---

2006-02-22   Viropro inc. Selects HKDP communications and public affairs

---

2006-02-02   Viropro inc. Announces term sheet for financing of up to a maximum of us $ 2.8 million

---

2005-12-01   Viropro inc. And nrc’s biotechnology research institute sign a scientific and technological agreement in principle

---